Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Autologous CD19/BCMA Dual-Target CAR-T for Relapsed/Refractory Autoimmune Diseases [Phase 1]
Phase 1 trial evaluating autologous CD19/BCMA dual-target CAR-T therapy for relapsed/refractory autoimmune diseases; currently recruiting at…
-
CLINICAL_TRIALS trial_result · 2026-01-22Clinical Trial Update: Self-Directed Positive Psychology Intervention for Newly Diagnosed Multiple Sclerosis [NA]
A completed trial evaluating a self-directed positive psychology intervention for individuals newly diagnosed with multiple sclerosis. Resul…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: CD19/BCMA-Targeted UCAR-T for Patients With Neurological Autoimmune Diseases [EARLY_Phase 1]
An early-phase UCAR-T therapy targeting CD19/BCMA is being evaluated for relapsing or refractory multiple sclerosis, myasthenia gravis, CIDP…
-
CLINICAL_TRIALS trial_result · 2026-01-22Clinical Trial Update: MS Fatigue and tDCS on Fatigue in Multiple Sclerosis [NA]
Completed clinical trial evaluating the effect of transcranial direct current stimulation on fatigue in people with multiple sclerosis.
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Early Detection of Selected Neuropathologies in Motor Vehicle Drivers
This clinical trial update describes an ongoing study led by University Hospital Olomouc to detect early markers of selected neuropathologie…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Myrosinase Bioactivated Gglucoraphanin for the Treatment of Neurodegenerative Diseases (GRA-MYR-ND) [NA]
This clinical trial update indicates that a study of myrosinase-activated glucoraphanin for neurodegenerative diseases is currently recruiti…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Impact of Annual Versus Biannual Infusions of Ocrelizumab in Patients With Active MS,After 2 Years of Initial Treatment, on Freedom From Radiological Disease Activity at Two Years: a Multicenter Randomized Controlled Non-inferiority Trial [Phase 3]
A Phase 3 randomized trial (currently recruiting) evaluating annual versus biannual infusions of ocrelizumab in patients with active multipl…
-
CLINICAL_TRIALS trial_result · 2026-01-21Clinical Trial Update: MS Synchronous vs Asynchronous Exercise Study [NA]
This clinical trial update notes completion of a study comparing synchronous versus asynchronous exercise in people with Multiple Sclerosis,…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Comparison of Digital Biomarkers in Subjects With Radiologically Isolated Syndrome (RIS) and Multiple Sclerosis (MS) Patients With Clinically Normal Neurological Examination [NA]
A clinical trial update indicates recruitment is ongoing for a study comparing digital biomarkers in radiologically isolated syndrome and mu…
-
CLINICAL_TRIALS other · 2026-01-21Clinical Trial Update: Tongji NADs Cohort
Tongji Hospital has announced a NADs cohort trial covering multiple autoimmune neurological diseases including multiple sclerosis and relate…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: This is an Early Exploratory Study to Assess the Tolerability and Safety of GC012F in Patients With Multiple Sclerosis [EARLY_Phase 1]
This clinical trial update describes an early Phase 1 exploratory study to assess tolerability and safety of GC012F in patients with multipl…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Home Based Functional Balance Intervention for Multiple Sclerosis [NA]
A clinical trial is recruiting to evaluate a home-based functional balance intervention for people with multiple sclerosis. The study appear…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Exercise Balance Program for Fall Prevention in Multiple Sclerosis [NA]
A clinical trial update noting that an exercise balance program aimed at reducing falls in people with multiple sclerosis is active but not …
-
FDA approval · 2026-01-16FDA Approved: FINGOLIMOD — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved a supplemental application for Fingolimod submitted by Glenmark Pharmaceuticals Inc., USA.
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: Effects of DHA in Patients With Multiple Sclerosis [NA]
This clinical trial update describes evaluating the effects of docosahexaenoic acid (DHA) in patients with multiple sclerosis, with enrollme…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: A Study of C-CAR168 in the Treatment of Central Nervous System Autoimmune Diseases Refractory to Standard Therapy [Phase 1]
This is a Phase 1 clinical trial evaluating the safety and feasibility of C-CAR168 for CNS autoimmune diseases. The study is not yet recruit…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: EXpain Trial - Exercise an a Non-pharmacological Pain-relieving Treatment in People With Multiple Sclerosis [NA]
The EXpain trial, sponsored by the University of Aarhus, tests a non-pharmacological, exercise-based method to relieve pain in people with m…
-
CLINICAL_TRIALS trial_result · 2026-01-14Clinical Trial Update: Pharmacogenomics of Drug Safety in Multiple Sclerosis
A completed clinical trial update examining pharmacogenomics in drug safety for multiple sclerosis.
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: Cannabis (THC vs. CBD) in Multiple Sclerosis [Phase 2]
This document provides a Phase 2 trial update comparing THC and CBD for multiple sclerosis. The trial is currently ACTIVE_NOT_RECRUITING.
-
EMA approval · 2026-01-13EMA Authorised: Mavenclad (cladribine) — Merck Europe B.V.
The EMA authorised Mavenclad (cladribine) from Merck Europe B.V. for multiple sclerosis, marking regulatory approval in the European Union.
-
CLINICAL_TRIALS trial_result · 2026-01-13Clinical Trial Update: Effects of Deep Sensory Assisted Rehabilitation on Gait and Balance in Patients With Multiple Sclerosis [NA]
A completed clinical trial evaluating deep sensory assisted rehabilitation to improve gait and balance in patients with Multiple Sclerosis.
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: Functional and Quality of Life Effects of the Mollii Neuromodulatory Suit in Patients With Stroke and Multiple Sclerosis [NA]
This clinical trial update describes the functional and quality-of-life effects of the Mollii neuromodulatory suit in patients with stroke a…
-
EMA approval · 2026-01-09EMA Authorised: Tysabri (natalizumab) — Biogen Netherlands B.V.
The European Medicines Agency authorised the marketing of Tysabri (natalizumab) by Biogen Netherlands B.V. for the treatment of Multiple Scl…
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: Effect of Training With Wireless Lightning Reaction Systems on Cognitive Functions in Individuals With Multiple Sclerosis [NA]
A clinical trial update describes a study evaluating training with a wireless lightning reaction system to assess cognitive function in indi…
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: Body Awareness, Trunk Stability, and Arm Function in MS
A clinical trial conducted at Hacettepe University is recruiting participants with Multiple Sclerosis to study body awareness, trunk stabili…